Cancer clinical trials in the region Auvergne-Rhône-Alpes
241 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 3
Breast cancer
#NCT06018337
HER2 Low
HR Positive
Locally Advanced
Metastatic
Targeted therapy
Hormone therapy
Chemotherapy
Antibody Drug Conjugates (ADC)
Hôpital Henri-Mondor AP-HP (Créteil), CHU Nîmes / Institut de cancérologie du Gard (Nîmes), Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier), Centre Hospitalier Universitaire Angers (Angers ), Centre Hospitalier Universitaire Dupuytren (Limoges) (and 11 more...)
DualityBio Inc.
Phase 3
Lymphoma
#NCT06006117
B cell lymphoma
Marginal zone lymphoma
None
> 60 ml/min
50-60 ml/min
30-50 ml/min
Targeted therapy
1
2
3 or more
Systemic Treatment-Naive
Bispecific T-cell engager antibodies
Allogeneic stem cell transplant
Centre Hospitalier d'Avignon (Avignon), Centre Hospitalier Régional d'Orléans Hôpital de La Source (Orléans), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), Centre Antoine Lacassagne (Nice), CHU Nice Hôpital l'Archet (Nice) (and 18 more...)
Organisation de recherche universitaire sur le lymphome
Phase 3
Lung cancer
#NCT05920356
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
KRAS G12C
Systemic Treatment-Naive
PDL1 Negative (< 1%)
Targeted therapy
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Centre Hospitalier de Cornouaille (Quimper), Centre Hospitalier Universitaire de Lille - Institut Cœur Poumon (Lille), Centre Hospitalier Universitaire de Nîmes (Nîmes), Institut Curie - Paris (Paris), CHU de Rennes - Hôpital Pontchaillou (Rennes) (and 18 more...)
Amgen
Phase 3
Breast cancer
#NCT05894239
HER2 Positive
Locally Advanced
Metastatic
PIK3CA
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Institut Sainte Catherine (Avignon), Centre Hospitalier de la Côte Basque (Bayonne), Polyclinique Bordeaux Nord Aquitaine (Bordeaux)
Hoffmann-La Roche
Phase 3
Breast cancer
#NCT05696626
HER2 Negative
HR Positive
Locally Advanced
Metastatic
ESR
Targeted therapy
Hormone therapy
Other mutation
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Institut Paoli-Calmettes (Marseille)
Sermonix Pharmaceuticals Inc.
Phase 3
Lung cancer
#NCT05687266
NSCLC (Non-Small Cell Lung Cancer)
Squamous NSCLC
Non-squamous NSCLC
Locally Advanced
Metastatic
Systemic Treatment-Naive
EGFR
BRAF
MET
ALK
RET
ROS-1
NTRK-1/2/3
Hôpital Cochin (Paris ), Hôpital Bichat - Claude Bernard - AP-HP (Paris), Hôpital Henri-Mondor AP-HP (Créteil), Centre Hospitalier Universitaire de Montpellier - Site Arnaud de Villeneuve (Montpellier), Centre Hospitalier Universitaire de Nîmes (Nîmes) (and 8 more...)
AstraZeneca
Phase 3
Lung cancer
#NCT05668988
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
EGFR
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Nantes (Nantes), Hôpital d'instruction des Armées Bégin (Saint-Mandé), Centre Hospitalier Universitaire Angers (Angers ), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Centre Hospitalier Universitaire de Grenoble (La Tronche) (and 7 more...)
Debiopharm International SA
Phase 3
Lung cancer
#NCT05607550
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
EGFR
Systemic Treatment-Naive
Immunotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Centre François Baclesse (Caen ), Centre Léon Bérard (Lyon), Hôpital de la Croix Rousse - Hospices Civils de Lyon (Lyon), Hôpital Nord de Marseille (Marseille Cedex 20), Gustave Roussy (Villejuif) (and 1 more...)
ArriVent BioPharma, Inc
Phase 3
Breast cancer
#NCT05296798
HER2 Positive
HR Positive
Locally Advanced
Metastatic
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Institut Sainte Catherine (Avignon), Centre Hospitalier de la Côte Basque (Bayonne), Centre Hospitalier Universitaire de Besançon (Besançon), Polyclinique Bordeaux Nord Aquitaine (Bordeaux), Centre Hospitalier Universitaire de Grenoble (La Tronche) (and 4 more...)
Hoffmann-La Roche
Phase 3
Lung cancer
#NCT05555732
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
Systemic Treatment-Naive
PDL1 Negative (< 1%)
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
EGFR
BRAF
MET
ALK
RET
ROS-1
NTRK-1/2/3
Other mutation
Immunotherapy
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Immunotherapy
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Centre Hospitalier Universitaire de Nantes (Nantes), Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Centre Léon Bérard (Lyon), Hôpital Foch (Suresnes) (and 5 more...)
Daiichi Sankyo